APO Research
Talk to an analyst

APO RESEARCH · REPORT

Opioid Analgesics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Opioid Analgesics Industry Growth and Trends Forecast to 2032

29 December 2025102 pages

Choose your research edition.

Industry ResearchOpioid Analgesics Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Opioid Analgesics Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Opioid Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Opioid Analgesics Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Opioid Analgesics Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Opioid Analgesics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Opioid Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Opioid Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Opioid Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Opioid Analgesics include Assertio Holdings, Inc, Bausch Health, Boehringer Ingelheim International GmbH, Endo International Plc, F. Hoffmann-La Roche AG, Purdue Pharmaceuticals L.P., Sanofi S.A., Teva Pharmaceuticals and Abbott Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Opioid Analgesics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Opioid Analgesics market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Opioid Analgesics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Opioid Analgesics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Opioid Analgesics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Opioid Analgesics Market by Company

Assertio Holdings, Inc

Bausch Health

Boehringer Ingelheim International GmbH

Endo International Plc

F. Hoffmann-La Roche AG

Purdue Pharmaceuticals L.P.

Sanofi S.A.

Teva Pharmaceuticals

Abbott Laboratories

Bayer AG

GlaxoSmithKline plc

Pfizer Inc.

Novartis AG

Johnson & Johnson

Opioid Analgesics Segment by Type

Morphine

Methadone

OxyContin

Vicodin

Others

Opioid Analgesics Segment by Application

Surgical Pain

Neuropathic Pain

Cancer Pain

Others

Opioid Analgesics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Opioid Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Analgesics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Opioid Analgesics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Opioid Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Morphine Table 2. Major Company of Methadone Table 3. Major Company of OxyContin Table 4. Major Company of Vicodin Table 5. Major Company of Others Table 6. Global Opioid Analgesics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Opioid Analgesics Sales by Type (2021-2026) & (Tons) Table 8. Global Opioid Analgesics Sales Market Share in Volume by Type (2021-2026) Table 9. Global Opioid Analgesics Sales by Type (2021-2026) & (US$ Million) Table 10. Global Opioid Analgesics Sales Market Share in Value by Type (2021-2026) Table 11. Global Opioid Analgesics Price by Type (2021-2026) & (US$/Ton) Table 12. Global Opioid Analgesics Sales by Type (2027-2032) & (Tons) Table 13. Global Opioid Analgesics Sales Market Share in Volume by Type (2027-2032) Table 14. Global Opioid Analgesics Sales by Type (2027-2032) & (US$ Million) Table 15. Global Opioid Analgesics Sales Market Share in Value by Type (2027-2032) Table 16. Global Opioid Analgesics Price by Type (2027-2032) & (US$/Ton) Table 17. North America Opioid Analgesics Sales by Type (2021-2026) & (Tons) Table 18. North America Opioid Analgesics Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Opioid Analgesics Sales by Type (2021-2026) & (Tons) Table 20. Europe Opioid Analgesics Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Opioid Analgesics Sales by Type (2021-2026) & (Tons) Table 22. Asia-Pacific Opioid Analgesics Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Opioid Analgesics Sales by Type (2021-2026) & (Tons) Table 24. Latin America Opioid Analgesics Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Opioid Analgesics Sales by Type (2021-2026) & (Tons) Table 26. Middle East and Africa Opioid Analgesics Sales by Type (2021-2026) & (US$ Million) Table 27. Opioid Analgesics Industry Trends Table 28. Opioid Analgesics Industry Drivers Table 29. Opioid Analgesics Industry Opportunities and Challenges Table 30. Opioid Analgesics Industry Restraints Table 31. Global Opioid Analgesics Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Opioid Analgesics Revenue Market Share by Company (2021-2026) Table 33. Global Opioid Analgesics Sales by Company (2021-2026) & (Tons) Table 34. Global Opioid Analgesics Sales Share by Company (2021-2026) Table 35. Global Opioid Analgesics Market Price by Company (2021-2026) & (US$/Ton) Table 36. Global Opioid Analgesics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Opioid Analgesics Major Company Production Sites and Headquarters Table 38. Global Opioid Analgesics Company, Product Type & Application Table 39. Global Opioid Analgesics Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Opioid Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Opioid Analgesics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Opioid Analgesics Sales by Region (2021-2026) & (Tons) Table 44. Global Opioid Analgesics Sales Market Share in Volume by Region (2021-2026) Table 45. Global Opioid Analgesics Sales by Region (2021-2026) & (US$ Million) Table 46. Global Opioid Analgesics Sales Market Share in Value by Region (2021-2026) Table 47. Global Opioid Analgesics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 48. Global Opioid Analgesics Sales by Region (2027-2032) & (Tons) Table 49. Global Opioid Analgesics Sales Market Share in Volume by Region (2027-2032) Table 50. Global Opioid Analgesics Sales by Region (2027-2032) & (US$ Million) Table 51. Global Opioid Analgesics Sales Market Share in Value by Region (2027-2032) Table 52. Global Opioid Analgesics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 53. Global Opioid Analgesics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Opioid Analgesics Sales by Application (2021-2026) & (Tons) Table 55. Global Opioid Analgesics Sales Market Share in Volume by Application (2021-2026) Table 56. Global Opioid Analgesics Sales by Application (2021-2026) & (US$ Million) Table 57. Global Opioid Analgesics Sales Market Share in Value by Application (2021-2026) Table 58. Global Opioid Analgesics Price by Application (2021-2026) & (US$/Ton) Table 59. Global Opioid Analgesics Sales by Application (2027-2032) & (Tons) Table 60. Global Opioid Analgesics Sales Market Share in Volume by Application (2027-2032) Table 61. Global Opioid Analgesics Sales by Application (2027-2032) & (US$ Million) Table 62. Global Opioid Analgesics Sales Market Share in Value by Application (2027-2032) Table 63. Global Opioid Analgesics Price by Application (2027-2032) & (US$/Ton) Table 64. North America Opioid Analgesics Sales by Application (2021-2026) & (Tons) Table 65. North America Opioid Analgesics Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Opioid Analgesics Sales by Application (2021-2026) & (Tons) Table 67. Europe Opioid Analgesics Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Opioid Analgesics Sales by Application (2021-2026) & (Tons) Table 69. Asia-Pacific Opioid Analgesics Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Opioid Analgesics Sales by Application (2021-2026) & (Tons) Table 71. Latin America Opioid Analgesics Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Opioid Analgesics Sales by Application (2021-2026) & (Tons) Table 73. Middle East and Africa Opioid Analgesics Sales by Application (2021-2026) & (US$ Million) Table 74. Assertio Holdings, Inc Company Information Table 75. Assertio Holdings, Inc Business Overview Table 76. Assertio Holdings, Inc Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. Assertio Holdings, Inc Opioid Analgesics Product Portfolio Table 78. Assertio Holdings, Inc Recent Development Table 79. Bausch Health Company Information Table 80. Bausch Health Business Overview Table 81. Bausch Health Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. Bausch Health Opioid Analgesics Product Portfolio Table 83. Bausch Health Recent Development Table 84. Boehringer Ingelheim International GmbH Company Information Table 85. Boehringer Ingelheim International GmbH Business Overview Table 86. Boehringer Ingelheim International GmbH Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. Boehringer Ingelheim International GmbH Opioid Analgesics Product Portfolio Table 88. Boehringer Ingelheim International GmbH Recent Development Table 89. Endo International Plc Company Information Table 90. Endo International Plc Business Overview Table 91. Endo International Plc Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 92. Endo International Plc Opioid Analgesics Product Portfolio Table 93. Endo International Plc Recent Development Table 94. F. Hoffmann-La Roche AG Company Information Table 95. F. Hoffmann-La Roche AG Business Overview Table 96. F. Hoffmann-La Roche AG Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 97. F. Hoffmann-La Roche AG Opioid Analgesics Product Portfolio Table 98. F. Hoffmann-La Roche AG Recent Development Table 99. Purdue Pharmaceuticals L.P. Company Information Table 100. Purdue Pharmaceuticals L.P. Business Overview Table 101. Purdue Pharmaceuticals L.P. Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 102. Purdue Pharmaceuticals L.P. Opioid Analgesics Product Portfolio Table 103. Purdue Pharmaceuticals L.P. Recent Development Table 104. Sanofi S.A. Company Information Table 105. Sanofi S.A. Business Overview Table 106. Sanofi S.A. Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 107. Sanofi S.A. Opioid Analgesics Product Portfolio Table 108. Sanofi S.A. Recent Development Table 109. Teva Pharmaceuticals Company Information Table 110. Teva Pharmaceuticals Business Overview Table 111. Teva Pharmaceuticals Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 112. Teva Pharmaceuticals Opioid Analgesics Product Portfolio Table 113. Teva Pharmaceuticals Recent Development Table 114. Abbott Laboratories Company Information Table 115. Abbott Laboratories Business Overview Table 116. Abbott Laboratories Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 117. Abbott Laboratories Opioid Analgesics Product Portfolio Table 118. Abbott Laboratories Recent Development Table 119. Bayer AG Company Information Table 120. Bayer AG Business Overview Table 121. Bayer AG Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 122. Bayer AG Opioid Analgesics Product Portfolio Table 123. Bayer AG Recent Development Table 124. GlaxoSmithKline plc Company Information Table 125. GlaxoSmithKline plc Business Overview Table 126. GlaxoSmithKline plc Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 127. GlaxoSmithKline plc Opioid Analgesics Product Portfolio Table 128. GlaxoSmithKline plc Recent Development Table 129. Pfizer Inc. Company Information Table 130. Pfizer Inc. Business Overview Table 131. Pfizer Inc. Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 132. Pfizer Inc. Opioid Analgesics Product Portfolio Table 133. Pfizer Inc. Recent Development Table 134. Novartis AG Company Information Table 135. Novartis AG Business Overview Table 136. Novartis AG Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 137. Novartis AG Opioid Analgesics Product Portfolio Table 138. Novartis AG Recent Development Table 139. Johnson & Johnson Company Information Table 140. Johnson & Johnson Business Overview Table 141. Johnson & Johnson Opioid Analgesics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 142. Johnson & Johnson Opioid Analgesics Product Portfolio Table 143. Johnson & Johnson Recent Development Table 144. North America Opioid Analgesics Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 145. North America Opioid Analgesics Sales by Country (2021-2026) & (Tons) Table 146. North America Opioid Analgesics Sales Market Share by Country (2021-2026) Table 147. North America Opioid Analgesics Sales Forecast by Country (2027-2032) & (Tons) Table 148. North America Opioid Analgesics Sales Market Share Forecast by Country (2027-2032) Table 149. North America Opioid Analgesics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. North America Opioid Analgesics Market Size by Country (2021-2026) & (US$ Million) Table 151. North America Opioid Analgesics Market Share by Country (2021-2026) Table 152. North America Opioid Analgesics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. North America Opioid Analgesics Market Share Forecast by Country (2027-2032) Table 154. Europe Opioid Analgesics Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 155. Europe Opioid Analgesics Sales by Country (2021-2026) & (Tons) Table 156. Europe Opioid Analgesics Sales Market Share by Country (2021-2026) Table 157. Europe Opioid Analgesics Sales Forecast by Country (2027-2032) & (Tons) Table 158. Europe Opioid Analgesics Sales Market Share Forecast by Country (2027-2032) Table 159. Europe Opioid Analgesics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Europe Opioid Analgesics Market Size by Country (2021-2026) & (US$ Million) Table 161. Europe Opioid Analgesics Market Share by Country (2021-2026) Table 162. Europe Opioid Analgesics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Europe Opioid Analgesics Market Share Forecast by Country (2027-2032) Table 164. Asia-Pacific Opioid Analgesics Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 165. Asia-Pacific Opioid Analgesics Sales by Country (2021-2026) & (Tons) Table 166. Asia-Pacific Opioid Analgesics Sales Market Share by Country (2021-2026) Table 167. Asia-Pacific Opioid Analgesics Sales Forecast by Country (2027-2032) & (Tons) Table 168. Asia-Pacific Opioid Analgesics Sales Market Share Forecast by Country (2027-2032) Table 169. Asia-Pacific Opioid Analgesics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Asia-Pacific Opioid Analgesics Market Size by Country (2021-2026) & (US$ Million) Table 171. Asia-Pacific Opioid Analgesics Market Share by Country (2021-2026) Table 172. Asia-Pacific Opioid Analgesics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Asia-Pacific Opioid Analgesics Market Share Forecast by Country (2027-2032) Table 174. Latin America Opioid Analgesics Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 175. Latin America Opioid Analgesics Sales by Country (2021-2026) & (Tons) Table 176. Latin America Opioid Analgesics Sales Market Share by Country (2021-2026) Table 177. Latin America Opioid Analgesics Sales Forecast by Country (2027-2032) & (Tons) Table 178. Latin America Opioid Analgesics Sales Market Share Forecast by Country (2027-2032) Table 179. Latin America Opioid Analgesics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Latin America Opioid Analgesics Market Size by Country (2021-2026) & (US$ Million) Table 181. Latin America Opioid Analgesics Market Share by Country (2021-2026) Table 182. Latin America Opioid Analgesics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Latin America Opioid Analgesics Market Share Forecast by Country (2027-2032) Table 184. Middle East and Africa Opioid Analgesics Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 185. Middle East and Africa Opioid Analgesics Sales by Country (2021-2026) & (Tons) Table 186. Middle East and Africa Opioid Analgesics Sales Market Share by Country (2021-2026) Table 187. Middle East and Africa Opioid Analgesics Sales Forecast by Country (2027-2032) & (Tons) Table 188. Middle East and Africa Opioid Analgesics Sales Market Share Forecast by Country (2027-2032) Table 189. Middle East and Africa Opioid Analgesics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Middle East and Africa Opioid Analgesics Market Size by Country (2021-2026) & (US$ Million) Table 191. Middle East and Africa Opioid Analgesics Market Share by Country (2021-2026) Table 192. Middle East and Africa Opioid Analgesics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Middle East and Africa Opioid Analgesics Market Share Forecast by Country (2027-2032) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Opioid Analgesics Distributors List Table 197. Opioid Analgesics Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Opioid Analgesics Image Figure 2. Global Opioid Analgesics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Opioid Analgesics Market Size (2021-2032) & (US$ Million) Figure 4. Global Opioid Analgesics Sales (2021-2032) & (Tons) Figure 5. Morphine Image Figure 6. Global Morphine Sales YoY Growth (2021-2032) & (Tons) Figure 7. Methadone Image Figure 8. Global Methadone Sales YoY Growth (2021-2032) & (Tons) Figure 9. OxyContin Image Figure 10. Global OxyContin Sales YoY Growth (2021-2032) & (Tons) Figure 11. Vicodin Image Figure 12. Global Vicodin Sales YoY Growth (2021-2032) & (Tons) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 15. Global Opioid Analgesics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Opioid Analgesics Market Share by Type 2025 VS 2032 Figure 17. North America Opioid Analgesics Sales Market Share in Volume by Type in 2025 Figure 18. North America Opioid Analgesics Sales Market Share in Value by Type in 2025 Figure 19. Europe Opioid Analgesics Sales Market Share in Volume by Type in 2025 Figure 20. Europe Opioid Analgesics Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Opioid Analgesics Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Opioid Analgesics Sales Market Share in Value by Type in 2025 Figure 23. Latin America Opioid Analgesics Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Opioid Analgesics Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Opioid Analgesics Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Opioid Analgesics Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Opioid Analgesics Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Surgical Pain Image Figure 30. Global Surgical Pain Sales YoY Growth (2021-2032) & (Tons) Figure 31. Neuropathic Pain Image Figure 32. Global Neuropathic Pain Sales YoY Growth (2021-2032) & (Tons) Figure 33. Cancer Pain Image Figure 34. Global Cancer Pain Sales YoY Growth (2021-2032) & (Tons) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 37. Global Opioid Analgesics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Opioid Analgesics Market Share by Application 2025 VS 2032 Figure 39. North America Opioid Analgesics Sales Market Share in Volume by Application in 2025 Figure 40. North America Opioid Analgesics Sales Market Share in Value by Application in 2025 Figure 41. Europe Opioid Analgesics Sales Market Share in Volume by Application in 2025 Figure 42. Europe Opioid Analgesics Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Opioid Analgesics Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Opioid Analgesics Sales Market Share in Value by Application in 2025 Figure 45. Latin America Opioid Analgesics Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Opioid Analgesics Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Opioid Analgesics Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Opioid Analgesics Sales Market Share in Value by Application in 2025 Figure 49. North America Opioid Analgesics Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. North America Opioid Analgesics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Opioid Analgesics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Opioid Analgesics Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Opioid Analgesics Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Europe Opioid Analgesics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Opioid Analgesics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Opioid Analgesics Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Opioid Analgesics Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Asia-Pacific Opioid Analgesics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Opioid Analgesics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Opioid Analgesics Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Opioid Analgesics Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 62. Latin America Opioid Analgesics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Opioid Analgesics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Opioid Analgesics Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Opioid Analgesics Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 66. Middle East and Africa Opioid Analgesics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Opioid Analgesics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Opioid Analgesics Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Opioid Analgesics Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Opioid Analgesics Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Morphine
  • Methadone
  • OxyContin
  • Vicodin
  • Others
Applications
  • Surgical Pain
  • Neuropathic Pain
  • Cancer Pain
  • Others
Companies covered
  • Assertio Holdings, Inc
  • Bausch Health
  • Boehringer Ingelheim International GmbH
  • Endo International Plc
  • F. Hoffmann-La Roche AG
  • Purdue Pharmaceuticals L.P.
  • Sanofi S.A.
  • Teva Pharmaceuticals
  • Abbott Laboratories
  • Bayer AG
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Novartis AG
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Opioid Analgesics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Opioid Analgesics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Opioid Analgesics Market by Type
  6. 1.3.1 Morphine
  7. 1.3.2 Methadone
  8. 1.3.3 OxyContin
  9. 1.3.4 Vicodin
  10. 1.3.5 Others
  11. 1.4 Global Opioid Analgesics Market Size by Type
  12. 1.4.1 Global Opioid Analgesics Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Opioid Analgesics Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Opioid Analgesics Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Opioid Analgesics Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Opioid Analgesics Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Opioid Analgesics Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Opioid Analgesics Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Opioid Analgesics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Opioid Analgesics Industry Trends
  2. 2.2 Opioid Analgesics Industry Drivers
  3. 2.3 Opioid Analgesics Industry Opportunities and Challenges
  4. 2.4 Opioid Analgesics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Opioid Analgesics Revenue (2021-2026)
  2. 3.2 Global Top Players by Opioid Analgesics Sales (2021-2026)
  3. 3.3 Global Top Players by Opioid Analgesics Price (2021-2026)
  4. 3.4 Global Opioid Analgesics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Opioid Analgesics Major Company Production Sites & Headquarters
  6. 3.6 Global Opioid Analgesics Company, Product Type & Application
  7. 3.7 Global Opioid Analgesics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Opioid Analgesics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Opioid Analgesics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Opioid Analgesics Tier 1, Tier 2, and Tier 3
4 Opioid Analgesics Regional Status and Outlook
  1. 4.1 Global Opioid Analgesics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Opioid Analgesics Historic Market Size by Region
  3. 4.2.1 Global Opioid Analgesics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Opioid Analgesics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Opioid Analgesics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Opioid Analgesics Forecasted Market Size by Region
  7. 4.3.1 Global Opioid Analgesics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Opioid Analgesics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Opioid Analgesics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Opioid Analgesics by Application
  1. 5.1 Opioid Analgesics Market by Application
  2. 5.1.1 Surgical Pain
  3. 5.1.2 Neuropathic Pain
  4. 5.1.3 Cancer Pain
  5. 5.1.4 Others
  6. 5.2 Global Opioid Analgesics Market Size by Application
  7. 5.2.1 Global Opioid Analgesics Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Opioid Analgesics Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Opioid Analgesics Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Opioid Analgesics Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Opioid Analgesics Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Opioid Analgesics Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Opioid Analgesics Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Opioid Analgesics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Assertio Holdings, Inc
  2. 6.1.1 Assertio Holdings, Inc Company Information
  3. 6.1.2 Assertio Holdings, Inc Business Overview
  4. 6.1.3 Assertio Holdings, Inc Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Assertio Holdings, Inc Opioid Analgesics Product Portfolio
  6. 6.1.5 Assertio Holdings, Inc Recent Developments
  7. 6.2 Bausch Health
  8. 6.2.1 Bausch Health Company Information
  9. 6.2.2 Bausch Health Business Overview
  10. 6.2.3 Bausch Health Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bausch Health Opioid Analgesics Product Portfolio
  12. 6.2.5 Bausch Health Recent Developments
  13. 6.3 Boehringer Ingelheim International GmbH
  14. 6.3.1 Boehringer Ingelheim International GmbH Company Information
  15. 6.3.2 Boehringer Ingelheim International GmbH Business Overview
  16. 6.3.3 Boehringer Ingelheim International GmbH Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boehringer Ingelheim International GmbH Opioid Analgesics Product Portfolio
  18. 6.3.5 Boehringer Ingelheim International GmbH Recent Developments
  19. 6.4 Endo International Plc
  20. 6.4.1 Endo International Plc Company Information
  21. 6.4.2 Endo International Plc Business Overview
  22. 6.4.3 Endo International Plc Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Endo International Plc Opioid Analgesics Product Portfolio
  24. 6.4.5 Endo International Plc Recent Developments
  25. 6.5 F. Hoffmann-La Roche AG
  26. 6.5.1 F. Hoffmann-La Roche AG Company Information
  27. 6.5.2 F. Hoffmann-La Roche AG Business Overview
  28. 6.5.3 F. Hoffmann-La Roche AG Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 F. Hoffmann-La Roche AG Opioid Analgesics Product Portfolio
  30. 6.5.5 F. Hoffmann-La Roche AG Recent Developments
  31. 6.6 Purdue Pharmaceuticals L.P.
  32. 6.6.1 Purdue Pharmaceuticals L.P. Company Information
  33. 6.6.2 Purdue Pharmaceuticals L.P. Business Overview
  34. 6.6.3 Purdue Pharmaceuticals L.P. Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Purdue Pharmaceuticals L.P. Opioid Analgesics Product Portfolio
  36. 6.6.5 Purdue Pharmaceuticals L.P. Recent Developments
  37. 6.7 Sanofi S.A.
  38. 6.7.1 Sanofi S.A. Company Information
  39. 6.7.2 Sanofi S.A. Business Overview
  40. 6.7.3 Sanofi S.A. Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sanofi S.A. Opioid Analgesics Product Portfolio
  42. 6.7.5 Sanofi S.A. Recent Developments
  43. 6.8 Teva Pharmaceuticals
  44. 6.8.1 Teva Pharmaceuticals Company Information
  45. 6.8.2 Teva Pharmaceuticals Business Overview
  46. 6.8.3 Teva Pharmaceuticals Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Teva Pharmaceuticals Opioid Analgesics Product Portfolio
  48. 6.8.5 Teva Pharmaceuticals Recent Developments
  49. 6.9 Abbott Laboratories
  50. 6.9.1 Abbott Laboratories Company Information
  51. 6.9.2 Abbott Laboratories Business Overview
  52. 6.9.3 Abbott Laboratories Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Abbott Laboratories Opioid Analgesics Product Portfolio
  54. 6.9.5 Abbott Laboratories Recent Developments
  55. 6.10 Bayer AG
  56. 6.10.1 Bayer AG Company Information
  57. 6.10.2 Bayer AG Business Overview
  58. 6.10.3 Bayer AG Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bayer AG Opioid Analgesics Product Portfolio
  60. 6.10.5 Bayer AG Recent Developments
  61. 6.11 GlaxoSmithKline plc
  62. 6.11.1 GlaxoSmithKline plc Company Information
  63. 6.11.2 GlaxoSmithKline plc Business Overview
  64. 6.11.3 GlaxoSmithKline plc Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 GlaxoSmithKline plc Opioid Analgesics Product Portfolio
  66. 6.11.5 GlaxoSmithKline plc Recent Developments
  67. 6.12 Pfizer Inc.
  68. 6.12.1 Pfizer Inc. Company Information
  69. 6.12.2 Pfizer Inc. Business Overview
  70. 6.12.3 Pfizer Inc. Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Pfizer Inc. Opioid Analgesics Product Portfolio
  72. 6.12.5 Pfizer Inc. Recent Developments
  73. 6.13 Novartis AG
  74. 6.13.1 Novartis AG Company Information
  75. 6.13.2 Novartis AG Business Overview
  76. 6.13.3 Novartis AG Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Novartis AG Opioid Analgesics Product Portfolio
  78. 6.13.5 Novartis AG Recent Developments
  79. 6.14 Johnson & Johnson
  80. 6.14.1 Johnson & Johnson Company Information
  81. 6.14.2 Johnson & Johnson Business Overview
  82. 6.14.3 Johnson & Johnson Opioid Analgesics Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Johnson & Johnson Opioid Analgesics Product Portfolio
  84. 6.14.5 Johnson & Johnson Recent Developments
7 North America by Country
  1. 7.1 North America Opioid Analgesics Sales by Country
  2. 7.1.1 North America Opioid Analgesics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Opioid Analgesics Sales by Country (2021-2026)
  4. 7.1.3 North America Opioid Analgesics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Opioid Analgesics Market Size by Country
  6. 7.2.1 North America Opioid Analgesics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Opioid Analgesics Market Size by Country (2021-2026)
  8. 7.2.3 North America Opioid Analgesics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Opioid Analgesics Sales by Country
  2. 8.1.1 Europe Opioid Analgesics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Opioid Analgesics Sales by Country (2021-2026)
  4. 8.1.3 Europe Opioid Analgesics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Opioid Analgesics Market Size by Country
  6. 8.2.1 Europe Opioid Analgesics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Opioid Analgesics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Opioid Analgesics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Opioid Analgesics Sales by Country
  2. 9.1.1 Asia-Pacific Opioid Analgesics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Opioid Analgesics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Opioid Analgesics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Opioid Analgesics Market Size by Country
  6. 9.2.1 Asia-Pacific Opioid Analgesics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Opioid Analgesics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Opioid Analgesics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Opioid Analgesics Sales by Country
  2. 10.1.1 South America Opioid Analgesics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Opioid Analgesics Sales by Country (2021-2026)
  4. 10.1.3 South America Opioid Analgesics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Opioid Analgesics Market Size by Country
  6. 10.2.1 South America Opioid Analgesics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Opioid Analgesics Market Size by Country (2021-2026)
  8. 10.2.3 South America Opioid Analgesics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Opioid Analgesics Sales by Country
  2. 11.1.1 Middle East and Africa Opioid Analgesics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Opioid Analgesics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Opioid Analgesics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Opioid Analgesics Market Size by Country
  6. 11.2.1 Middle East and Africa Opioid Analgesics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Opioid Analgesics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Opioid Analgesics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Opioid Analgesics Value Chain Analysis
  2. 12.1.1 Opioid Analgesics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Opioid Analgesics Production Mode & Process
  7. 12.2 Opioid Analgesics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Opioid Analgesics Distributors
  10. 12.2.3 Opioid Analgesics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst